DK1573323T3 - Prion-proteinligander samt fremgangsmåder til anvendelse deraf - Google Patents

Prion-proteinligander samt fremgangsmåder til anvendelse deraf

Info

Publication number
DK1573323T3
DK1573323T3 DK03808431.5T DK03808431T DK1573323T3 DK 1573323 T3 DK1573323 T3 DK 1573323T3 DK 03808431 T DK03808431 T DK 03808431T DK 1573323 T3 DK1573323 T3 DK 1573323T3
Authority
DK
Denmark
Prior art keywords
prion protein
ligands
prion
methods
protein ligands
Prior art date
Application number
DK03808431.5T
Other languages
English (en)
Inventor
David J Hammond
Julia T Lathrop
Larisa Cervenakova
Ruben G Carbonell
Original Assignee
Pathogen Removal & Diagnostic Technologies Inc
Univ North Carolina State
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pathogen Removal & Diagnostic Technologies Inc, Univ North Carolina State filed Critical Pathogen Removal & Diagnostic Technologies Inc
Application granted granted Critical
Publication of DK1573323T3 publication Critical patent/DK1573323T3/da

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0802—Tripeptides with the first amino acid being neutral
    • C07K5/0804—Tripeptides with the first amino acid being neutral and aliphatic
    • C07K5/0808—Tripeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms, e.g. Val, Ile, Leu
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0802—Tripeptides with the first amino acid being neutral
    • C07K5/0804—Tripeptides with the first amino acid being neutral and aliphatic
    • C07K5/081—Tripeptides with the first amino acid being neutral and aliphatic the side chain containing O or S as heteroatoms, e.g. Cys, Ser
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0802—Tripeptides with the first amino acid being neutral
    • C07K5/0812—Tripeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0819—Tripeptides with the first amino acid being acidic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0821—Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/28—Neurological disorders
    • G01N2800/2814—Dementia; Cognitive disorders
    • G01N2800/2828—Prion diseases

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK03808431.5T 2002-12-03 2003-12-03 Prion-proteinligander samt fremgangsmåder til anvendelse deraf DK1573323T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US43042302P 2002-12-03 2002-12-03
PCT/US2003/038343 WO2004050851A2 (en) 2002-12-03 2003-12-03 Prion protein ligands and methods of use

Publications (1)

Publication Number Publication Date
DK1573323T3 true DK1573323T3 (da) 2012-01-23

Family

ID=32469468

Family Applications (4)

Application Number Title Priority Date Filing Date
DK03808431.5T DK1573323T3 (da) 2002-12-03 2003-12-03 Prion-proteinligander samt fremgangsmåder til anvendelse deraf
DK10176707T DK2317317T3 (da) 2002-12-03 2003-12-03 Prion-proteinligander samt fremgangsmåder til anvendelse deraf
DK10176708T DK2312318T3 (da) 2002-12-03 2003-12-03 Prion-proteinligander samt fremgangsmåder til anvendelse deraf
DK08150151T DK1953551T3 (da) 2002-12-03 2003-12-03 Prion-proteinligander samt fremgangsmåder til anvendelse deraf

Family Applications After (3)

Application Number Title Priority Date Filing Date
DK10176707T DK2317317T3 (da) 2002-12-03 2003-12-03 Prion-proteinligander samt fremgangsmåder til anvendelse deraf
DK10176708T DK2312318T3 (da) 2002-12-03 2003-12-03 Prion-proteinligander samt fremgangsmåder til anvendelse deraf
DK08150151T DK1953551T3 (da) 2002-12-03 2003-12-03 Prion-proteinligander samt fremgangsmåder til anvendelse deraf

Country Status (15)

Country Link
US (3) US7863411B2 (da)
EP (4) EP2312318B1 (da)
JP (1) JP4485367B2 (da)
CN (3) CN1739029B (da)
AT (1) ATE529744T1 (da)
AU (2) AU2003302500B2 (da)
CA (2) CA2507936C (da)
DK (4) DK1573323T3 (da)
ES (4) ES2375958T3 (da)
HK (4) HK1088948A1 (da)
IL (3) IL168904A (da)
MX (2) MXPA05005920A (da)
NZ (3) NZ560410A (da)
PT (4) PT2317317E (da)
WO (1) WO2004050851A2 (da)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7166471B2 (en) 2001-05-31 2007-01-23 Arete Associates Misfolded protein sensor method in body fluids
US20050026165A1 (en) * 2001-05-31 2005-02-03 Cindy Orser Detection of conformationally altered proteins and prions
CA2507936C (en) 2002-12-03 2014-02-25 The American National Red Cross Prion protein ligands and methods of use
EP1616036A4 (en) * 2003-04-14 2007-03-21 Pathogen Removal And Diagnosti PROCESS FOR IDENTIFYING LIGANDS SPECIFIC TO STRUCTURAL FORMS OF PROTEINS
US20060035242A1 (en) * 2004-08-13 2006-02-16 Michelitsch Melissa D Prion-specific peptide reagents
WO2005016127A2 (en) 2003-08-13 2005-02-24 Chiron Corporation Prion-specific peptide reagents
US20060057671A1 (en) * 2004-09-10 2006-03-16 Orser Cindy S Immobilized probes and methods of detecting conformationally altered prion proteins
JP5048522B2 (ja) * 2005-02-15 2012-10-17 エイディーライフ インコーポレイティッド 誤って折り畳まれたタンパク質およびプリオンを検出する方法
US7834144B2 (en) 2005-09-09 2010-11-16 Novartis Ag Prion-specific peptoid reagents
US8168181B2 (en) 2006-02-13 2012-05-01 Alethia Biotherapeutics, Inc. Methods of impairing osteoclast differentiation using antibodies that bind siglec-15
US7989160B2 (en) 2006-02-13 2011-08-02 Alethia Biotherapeutics Inc. Polynucleotides and polypeptide sequences involved in the process of bone remodeling
WO2008005960A2 (en) * 2006-07-07 2008-01-10 Pall Corporation Prion processing
MX2009001079A (es) * 2006-07-28 2009-02-10 Adlyfe Inc Sondas de peptido para diagnosis y terapeutica.
CA2675039A1 (en) * 2007-01-12 2008-07-17 Alicon Ag Method for removing prion protein
AU2009243060A1 (en) * 2008-04-30 2009-11-05 Novartis Ag. Assay for pathogenic conformers
DK2419732T3 (da) * 2009-04-15 2019-12-16 Abraxis Bioscience Llc Prionfrie nanopartikelsammensætninger og fremgangsmåder
CA2755948A1 (en) 2009-05-21 2010-11-25 Larisa Cervenakova Inhibition of prion protein propagation by receptor associated protein (rap), its derivatives, mimetics and synthetic peptides
US8841429B2 (en) * 2009-11-03 2014-09-23 Vivonics, Inc. Nucleic acid ligands against infectious prions
US20130109581A1 (en) * 2009-11-04 2013-05-02 David Peretz Positively charged species as binding reagents in the separation of protein aggregates from monomers
US9162223B2 (en) 2011-12-21 2015-10-20 North Carolina State University Alkaline-stable chromatographic resins
ES2723885T3 (es) 2012-07-19 2019-09-03 Daiichi Sankyo Co Ltd Anticuerpos anti-Siglec-15
CN103336124B (zh) * 2012-12-11 2015-07-15 武汉工业学院 一种检测朊病毒蛋白(PrPSC)的方法和试剂盒
EP2995621A1 (en) 2014-09-10 2016-03-16 Previpharma AG Ligands and methods for isolating or removing proteins
CN113376364A (zh) 2015-08-10 2021-09-10 Essenlix 公司 步骤简化、小样品、快速、易使用的生物/化学分析装置和方法
CA2998587C (en) 2015-09-14 2023-01-10 Essenlix Corp. Device and system for analyzing a sample, particularly blood, as well as methods of using the same
CN108633304B (zh) 2015-09-14 2020-08-14 艾森利克斯公司 采集分析蒸汽凝析，特别是呼出气凝析的装置与系统，以及使用方法
CN110312473B (zh) 2016-12-21 2023-04-07 艾森利克斯公司 用于认证样本的装置和方法及其使用
WO2018148342A1 (en) 2017-02-07 2018-08-16 Essenlix Corporation Compressed open flow assay and use
WO2018148470A1 (en) 2017-02-08 2018-08-16 Essenlix Corporation Sample collection and handling for delayed analysis
CA3053002A1 (en) 2017-02-08 2018-08-16 Essenlix Corp. Bio/chemical material extraction and assay
CN111433606B (zh) 2017-02-09 2024-05-24 上海宜晟生物科技有限公司 采用不同间距高度的测定
CN110770572B (zh) 2017-02-09 2023-08-18 Essenlix公司 比色测定
US11940382B2 (en) 2017-02-09 2024-03-26 Essenlix Corporation Assay with amplification
CN111448449A (zh) 2017-02-16 2020-07-24 Essenlix公司 采用纹理化表面的测定
EP3406632A1 (en) 2017-05-23 2018-11-28 S.I.S.S.A. Scuola Internazionale Superiore di Studi Avanzati Ligands binding to prion protein for use in the treatment of synucleinopathies
US11243201B2 (en) 2017-08-01 2022-02-08 Essenlix Corporation Sample collection, holding and assaying
CN112689758A (zh) 2017-08-01 2021-04-20 Essenlix公司 检查药物对微生物影响的装置和方法
US11280706B2 (en) 2017-08-01 2022-03-22 Essenlix Corporation Dilution calibration
US11393561B2 (en) 2017-10-13 2022-07-19 Essenlix Corporation Devices and methods for authenticating a medical test and use of the same
US11609224B2 (en) 2017-10-26 2023-03-21 Essenlix Corporation Devices and methods for white blood cell analyses
US10807095B2 (en) 2017-10-26 2020-10-20 Essenlix Corporation Making and tracking assay card
US11237113B2 (en) 2017-10-26 2022-02-01 Essenlix Corporation Rapid pH measurement
US11648551B2 (en) 2017-12-12 2023-05-16 Essenlix Corporation Sample manipulation and assay with rapid temperature change
CN112534259A (zh) 2017-12-14 2021-03-19 Essenlix公司 监测毛发的装置，系统和方法
US11156606B2 (en) 2018-01-11 2021-10-26 Essenlix Corporation Homogeneous assay (II)
US11885952B2 (en) 2018-07-30 2024-01-30 Essenlix Corporation Optics, device, and system for assaying and imaging
JP7376040B2 (ja) * 2019-09-03 2023-11-08 国立大学法人京都工芸繊維大学 神経変性疾患におけるバイオマーカー分子の検出方法

Family Cites Families (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3601398A1 (de) * 1986-01-18 1987-07-23 Fresenius Ag Verwendung von oligopeptiden zur behandlung von cerebralen stoerungen
US5133866A (en) * 1988-03-24 1992-07-28 Terrapin Technologies, Inc. Method to identify analyte-bending ligands
US5010175A (en) * 1988-05-02 1991-04-23 The Regents Of The University Of California General method for producing and selecting peptides with specific properties
DE68905387T2 (de) * 1988-06-22 1993-10-21 Ajinomoto Kk Aminosäure-Nahrungsmittelzusammensetzungen.
WO1991005262A1 (en) * 1989-10-02 1991-04-18 University Of Michigan Bioanalytical detection system
US5498538A (en) * 1990-02-15 1996-03-12 The University Of North Carolina At Chapel Hill Totally synthetic affinity reagents
CA2077665A1 (en) 1990-03-05 1991-09-06 Robert Siman Chymotrypsin-like proteases and their inhibitors
US5416013A (en) * 1990-04-04 1995-05-16 Sterling Winthrop Inc. Interleukin 1β protease and interleukin 1β protease inhibitors
US6995141B1 (en) * 1990-04-04 2006-02-07 Vertex Pharmaceuticals Incorporated Interleukin 1β protease and interleukin 1β protease inhibitors
US5650489A (en) 1990-07-02 1997-07-22 The Arizona Board Of Regents Random bio-oligomer library, a method of synthesis thereof, and a method of use thereof
GB9024005D0 (en) * 1990-11-05 1990-12-19 British Bio Technology Process for amplifying nucleic acid
CA2124953C (en) * 1991-12-03 2008-02-05 Robert V. Fishleigh Peptides related to prion proteins
US5312730A (en) * 1992-05-27 1994-05-17 Ciba Corning Diagnostics Corp. Immune complex transfer with lypophilic bridge
CA2109646C (en) * 1992-11-24 2000-03-07 Gaston O. Daumy Para-nitroanilide peptides
JPH08178926A (ja) * 1994-10-25 1996-07-12 Sumitomo Pharmaceut Co Ltd イムノアッセイプレートおよびその用途
US5834318A (en) 1995-05-10 1998-11-10 Bayer Corporation Screening of combinatorial peptide libraries for selection of peptide ligand useful in affinity purification of target proteins
US5948763A (en) * 1995-06-07 1999-09-07 New York University Peptides and pharmaceutical compositions thereof for treatment of disorders or diseases associated with abnormal protein folding into amyloid or amyloid-like deposits
AU7142796A (en) * 1995-10-02 1997-04-28 Erasmus University Rotterdam Diagnosis method and reagents
US5750361A (en) 1995-11-02 1998-05-12 The Regents Of The University Of California Formation and use of prion protein (PRP) complexes
DE69724619T2 (de) * 1996-05-14 2004-07-01 Winnacker, Ernst-Ludwig, Prof. Chaperone, die prionproteine binden und zwischen den isoformen prpc und prpsc unterscheiden können
EP0920630B1 (en) * 1996-05-29 2002-07-31 McGILL UNIVERSITY Prion binding proteins and uses thereof
US5808011A (en) 1996-07-01 1998-09-15 Biopure Corporation Method for chromatographic removal of prions
US6126939A (en) * 1996-09-03 2000-10-03 Yeda Research And Development Co. Ltd. Anti-inflammatory dipeptide and pharmaceutical composition thereof
JPH10182695A (ja) * 1996-12-27 1998-07-07 Teikoku Seiyaku Co Ltd ｇｐ１２０に対して親和性を有するペプチド
US6221614B1 (en) * 1997-02-21 2001-04-24 The Regents Of The University Of California Removal of prions from blood, plasma and other liquids
GB9710582D0 (en) * 1997-05-22 1997-07-16 Oxford Glycosciences Uk Ltd A method for de novo peptide sequence determination
US6211149B1 (en) * 1998-08-03 2001-04-03 The United States Of America As Represented By The Department Of Health And Human Services Inhibitors of formation of protease resistant prion protein
US6750025B1 (en) * 1998-07-09 2004-06-15 V.I. Technologies, Inc. Method of detecting and isolating prion protein and variants thereof
DE19917838A1 (de) * 1999-01-12 2000-07-13 Bundesrepublik Deutschland Let Arzneimittel zur prophylaktischen oder therapeutischen Behandlung von transmissiblen spongiformen Enzephalopathien, Morbus Alzheimer und Corea Huntington und anderen neurodegenerativen Erkrankungen sowie diagnostische Mittel
EP1181058A2 (de) * 1999-05-27 2002-02-27 Max-Delbrück-Centrum Für Molekulare Medizin Vakzine gegen konformationsabhängige antigene sowie gegen antigene, die keine oder nicht ausschliesslich proteine oder peptide sind
JP2003521477A (ja) * 1999-06-23 2003-07-15 カプリオン ファーマシューティカルズ インコーポレーティッド プリオン蛋白質ペプチドおよびその使用
WO2001000235A1 (en) * 1999-06-29 2001-01-04 Mcgill University Prion protein binding proteins and uses thereof
US6261790B1 (en) * 1999-07-15 2001-07-17 The United States Of America As Represented By The Secretary Of Agriculture Monoclonal antibodies and antibody cocktail for detection of prion protein as an indication of transmissible spongiform encephalopathies
JP2003531570A (ja) * 1999-07-27 2003-10-28 アブジェニックス インク． 神経障害に関連したポリペプチド蓄積を阻害する方法および組成物
WO2001019867A1 (de) * 1999-09-14 2001-03-22 Memorec Stoffel Gmbh Prionen-verwandtes protein
US6437102B1 (en) * 1999-11-24 2002-08-20 Bayer Corporation Method of separating prions from biological materials
WO2001071042A2 (en) * 2000-03-23 2001-09-27 Pe Corporation (Ny) Detection kits, such as nucleic acid arrays, for detecting the expression of 10,000 or more drosophila genes and uses thereof
AU2001251358A1 (en) * 2000-04-05 2001-10-23 V.I. Technologies, Inc. Prion-binding ligands and methods of using same
US20020155808A1 (en) * 2000-04-12 2002-10-24 Harumi Kawamura Data transmission method and data transmission apparatus
GB0009918D0 (en) 2000-04-20 2000-06-07 Rose Keith Covalent capture facilitating purification of polypeptides
US20020155106A1 (en) * 2000-12-01 2002-10-24 Hammond David J. Method of identifying a ligand for a target molecule
WO2003016904A2 (en) 2001-08-13 2003-02-27 Campbell Douglas A Peptide sequence tags and method of using same
DE10152677A1 (de) * 2001-10-19 2003-05-08 Aventis Behring Gmbh Antikörper zum spezifischen Nachweis von pathogenen Prionen humanen Ursprungs und damit durchgeführten Nachweisverfahren
JP2003149461A (ja) * 2001-11-12 2003-05-21 Allied Tereshisu Kk 収納装置
CA2507936C (en) * 2002-12-03 2014-02-25 The American National Red Cross Prion protein ligands and methods of use
AU2004227389B2 (en) * 2003-04-04 2010-09-16 North Carolina State University Prion protein binding materials and methods of use
US7510848B2 (en) * 2003-04-04 2009-03-31 North Carolina State University Prion protein binding materials and methods of use
WO2006102099A2 (en) 2005-03-18 2006-09-28 The Regents Of The University Of California ANTIBODIES SPECIFIC FOR HUMAN AND BOVINE PrP

Also Published As

Publication number Publication date
CN102241741A (zh) 2011-11-16
HK1088948A1 (en) 2006-11-17
CA2836951C (en) 2017-01-10
DK1953551T3 (da) 2014-05-12
AU2010201499B2 (en) 2013-02-07
CA2507936C (en) 2014-02-25
CN102297798A (zh) 2011-12-28
NZ572892A (en) 2010-03-26
DK2312318T3 (da) 2015-01-12
AU2010201499A1 (en) 2010-05-06
HK1157009A1 (en) 2012-06-22
US20040229280A1 (en) 2004-11-18
DK2317317T3 (da) 2015-03-02
EP1953551A3 (en) 2009-03-18
WO2004050851A3 (en) 2005-01-27
PT1953551E (pt) 2014-05-06
AU2003302500A1 (en) 2004-06-23
NZ560410A (en) 2008-12-24
ES2375958T3 (es) 2012-03-07
US7863411B2 (en) 2011-01-04
CN1739029B (zh) 2011-06-22
IL200468A0 (en) 2011-07-31
IL168904A (en) 2010-11-30
ATE529744T1 (de) 2011-11-15
MX337569B (es) 2016-03-09
EP2317317B1 (en) 2014-11-26
EP1573323B1 (en) 2011-10-19
IL206129A (en) 2013-11-28
CN1739029A (zh) 2006-02-22
EP1573323A2 (en) 2005-09-14
HK1157010A1 (en) 2012-06-22
EP1953551A2 (en) 2008-08-06
CN102297798B (zh) 2015-11-18
CA2507936A1 (en) 2004-06-17
AU2003302500B2 (en) 2010-04-29
ES2460641T3 (es) 2014-05-14
IL200468A (en) 2012-06-28
EP2312318B1 (en) 2014-10-08
EP2317317A1 (en) 2011-05-04
EP1573323A4 (en) 2007-04-04
PT2317317E (pt) 2015-03-02
US8604161B2 (en) 2013-12-10
WO2004050851A2 (en) 2004-06-17
JP2006509013A (ja) 2006-03-16
CA2836951A1 (en) 2004-06-17
NZ540417A (en) 2008-04-30
PT1573323E (pt) 2012-01-10
CN102241741B (zh) 2013-11-13
IL206129A0 (en) 2010-11-30
US20140206021A1 (en) 2014-07-24
HK1124388A1 (en) 2009-07-10
PT2312318E (pt) 2015-01-14
US20080268474A1 (en) 2008-10-30
EP1953551B1 (en) 2014-02-19
JP4485367B2 (ja) 2010-06-23
MXPA05005920A (es) 2006-03-17
ES2531926T3 (es) 2015-03-20
EP2312318A1 (en) 2011-04-20
ES2527408T3 (es) 2015-01-23
US9678085B2 (en) 2017-06-13

Similar Documents

Publication Publication Date Title
DK1573323T3 (da) Prion-proteinligander samt fremgangsmåder til anvendelse deraf
DK1615992T3 (da) Prionproteinbindende materialer og fremgangsmåder til anvendelse
TNSN07136A1 (en) Prion protein binding materials and methods of use
TW200621798A (en) Sequential protein isolation and purification schemes by affinity chromatography
ATE441669T1 (de) Stabile lagerung von protein und stabile lagerung von nukleinsäure in wiedergewinnbarer form
DE602004003842D1 (de) Verfahren und automatisiertes Microfluidsystem zum Nachweis von Proteinen in biologischen Proben
ATE545460T1 (de) Proteomanalyseverfahren für phosphoryliertes protein
ATE514950T1 (de) Verfahren zur untersuchung von sepsis bei menschen
ATE431854T1 (de) Auf bio-barcodes beruhender nachweis von zielanalyten
DE602006013143D1 (de) Verfahren zum nachweis aggregatbildender zirkulierender proteinformen und mittel zum einfangen gebildeter aggregate
ATE537448T1 (de) Nachweis von rho-proteinen
Cleland Solid digestion of demineralized bone as a method to access potentially insoluble proteins and post-translational modifications
ATE547161T1 (de) Verfahren zur quantitativen bestimmung von poloxameren
ATE533055T1 (de) Verfahren zum screenen mithilfe von konformationsempfindlichen peptiden
ATE354095T1 (de) Verfahren zur detektion von prp unter verwendung ein makrozyklischen ligand
DE602004011228D1 (de) Verfahren und zusammensetzungen zur bestimmung glycierter proteine
ATE412187T1 (de) Screening test
ATE443871T1 (de) Test zum nachweis von pathologischen prionen
WO2007060373A3 (fr) Procede d'identification du genotype en position 171 de la proteine prion d'ovin ainsi que trousses de mise en oeuvre de ce procede
ATE356997T1 (de) Verfahren zur trennung und/oder zum nachweis und/oder zur identifizierung und/oder zur quantifizierung von prionproteinen
ATE477493T1 (de) Verfahren und diagnostisches kit zur simultanen identifizierung und quantifizierung von einzelnen oder in gemischen vorliegenden biomolekülen und deren modifikationen
ATE422674T1 (de) Verfahren zur analyse n-terminaler proteinaddukte
DE602004006434D1 (de) Proteomwechselwirkungskartierung
DE60325857D1 (de) Verfahren zur serologischen diagnose